[HTML][HTML] The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease

A Mori, JF Chen, S Uchida, C Durlach, SM King… - Molecules, 2022 - mdpi.com
The adenosine A2A receptor subtype is recognized as a non-dopaminergic
pharmacological target for the treatment of neurodegenerative disorders, notably …

[HTML][HTML] Metabolic aspects of adenosine functions in the brain

M Garcia-Gil, M Camici, S Allegrini, R Pesi… - Frontiers in …, 2021 - frontiersin.org
Adenosine, acting both through G-protein coupled adenosine receptors and intracellularly,
plays a complex role in multiple physiological and pathophysiological processes by …

[HTML][HTML] Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism

L Andreoli, M Abbaszadeh, X Cao, MA Cenci - Neurobiology of Disease, 2021 - Elsevier
Abstract L-DOPA-induced dyskinesia (LID) is a significant complication of dopamine
replacement therapy in Parkinson's disease (PD), and the specific role of different dopamine …

[HTML][HTML] Computational Studies Applied to Linalool and Citronellal Derivatives Against Alzheimer's and Parkinson's Disorders: A Review with Experimental Approach

PR da Silva, JC de Andrade, NF de Sousa… - Current …, 2023 - ncbi.nlm.nih.gov
Alzheimer's and Parkinson's are neurodegenerative disorders that affect a great number of
people around the world, seriously compromising the quality of life of individuals, due to …

[HTML][HTML] Adenosine A2A receptor availability in patients with early- and moderate-stage Parkinson's disease

I Waggan, E Rissanen, J Tuisku, J Joutsa, S Helin… - Journal of …, 2023 - Springer
Abstract Introduction Adenosine 2A (A2A) receptors co-localize with dopamine D2 receptors
in striatopallidal medium spiny neurons of the indirect pathway. A2A receptor activation in …

Enriching adenosine by thymine-rich DNA oligomers

M Liu, H Chen, Y Huang, J Liu, Q Chen, H Zuo, L Fang… - Analyst, 2023 - pubs.rsc.org
Adenosine levels are important in various physiological and pathological activities, but
detecting them is difficult because of interference from a complex matrix. This study …

N6-substituated adenosine analog J4 attenuates anxiety-like behaviors in mice

L Peyton, BE León, H Essa, Y Chern, DS Choi - Psychopharmacology, 2022 - Springer
Rationale Withdrawal from chronic alcohol exposure produces various physical and mental
withdrawal symptoms. Activation of adenosine receptors is known to inhibit withdrawal …

Koffein, Schokolade und Adenosin A2A Rezeptorantagonisten in der Behandlung des Parkinson Syndroms

H Reichmann - Fortschritte der Neurologie· Psychiatrie, 2023 - thieme-connect.com
Hintergrund Patienten mit einem idiopathischen Parkinson-Syndrom können offenbar vom
Koffeinkonsum profitieren, wie bereits eine Reihe experimenteller und klinischer Studien …

[PDF][PDF] Caffeine, chocolate, and adenosine antagonism in Parkinson's disease

H Reichmann - 2022 - f.oaes.cc
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
generally accepted that dopamine replacement therapy substantially improves motor …

[PDF][PDF] Effect of Adenosine Receptor Modulation on Caffeine-Induced Motor Activity in Rats

RH Thabet, YR Helmy - Clinical Reviews and Case Reports, 2023 - clinicsearchonline.org
Controversies regarding benefits and risks of coffee consumption still exist, but the limitless
health-promoting benefits of coffee outclass its few reported toxic effects. This study is …